NA
GILD icon

Nautilus Advisors’s Gilead Sciences GILD Stock Holding History

Nautilus Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$912K Buy
7,021
+37
+0.5% +$4.88K 0.54% 53
2026
Q1 		$973K Sell
6,984
-10
-0.1% -$1.4K 0.67% 42
2025
Q4 		$858K Sell
6,994
-164
-2% -$19.9K 0.56% 50
2025
Q3 		$795K Buy
7,158
+1
+0% +$114 0.53% 52
2025
Q2 		$793K Hold
7,157
– – 0.58% 44
2025
Q1 		$802K Sell
7,157
-75
-1% -$7.74K 0.66% 44
2024
Q4 		$668K Buy
+7,232
New +$651K 0.53% 56

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nautilus Advisors's GILD Position: Q2 2026 in Review

Nautilus Advisors increased its Gilead Sciences (GILD) stake by 0.53% in Q2 2026, buying an estimated $4.88K and bringing the position to 7,021 shares worth $912K. The position accounts for 0.54% of the portfolio, ranked #53.

Nautilus Advisors first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $973K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Nautilus Advisors held 7,021 shares of Gilead Sciences worth $912K as of Q2 2026.
  • Nautilus Advisors bought 37 Gilead Sciences shares in Q2 2026, an estimated $4.88K.
  • Gilead Sciences made up 0.54% of Nautilus Advisors's portfolio in Q2 2026, its #53 holding.
  • Nautilus Advisors first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Nautilus Advisors's Gilead Sciences position peaked at $973K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Nautilus Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.